Blankestijn P J, Vos P F, Rabelink T J, van Rijn H J, Jansen H, Koomans H A
Department of Nephrology, University Hospital, Utrecht, The Netherlands.
J Am Soc Nephrol. 1995 Mar;5(9):1703-8. doi: 10.1681/ASN.V591703.
In a controlled prospective trial, the effect of a switch from cellulose-based, low-flux dialysis membranes to polysulphone, high-flux membranes on lipid parameters was evaluated. Baseline values of lipid parameters were identical in the study group and the control group in which the dialysis membrane remained unchanged. After 6 wk, total triglyceride, very low-density lipoprotein (VLDL) triglyceride, and VLDL cholesterol decreased, respectively, 28 +/- 17 (P < 0.01), 38 +/- 17 (P < 0.01), and 24 +/- 21% (P < 0.05), and the proportion of total cholesterol that was high-density lipoprotein cholesterol increased from 15 +/- 5 to 18 +/- 5% (P < 0.05) in the high-flux polysulphone group, whereas these variables remained unchanged in the control group. Low-density lipoprotein and total cholesterol as well as Kt/V, protein catabolic rate, parathyroid hormone, albumin, and body weight did not change. No change in lipoprotein lipase activity was found. In a second study, the effects of a single hemodialysis session with high-flux polysulphone and low-flux, cellulose-based membranes on lipid parameters and lipolytic activity were compared in a cross-over fashion. Treatment with both membranes resulted in a significant decrease in plasma triglyceride, VLDL triglyceride, and VLDL cholesterol. Lipoprotein lipase activity increased during hemodialysis. Changes in lipid parameters and lipolytic activity were identical during the two treatments.
在一项对照前瞻性试验中,评估了从纤维素基低通量透析膜切换到聚砜高通量膜对脂质参数的影响。研究组和透析膜未改变的对照组的脂质参数基线值相同。6周后,高通量聚砜组的总甘油三酯、极低密度脂蛋白(VLDL)甘油三酯和VLDL胆固醇分别下降了28±17(P<0.01)、38±17(P<0.01)和24±21%(P<0.05),高密度脂蛋白胆固醇占总胆固醇的比例从15±5增加到18±5%(P<0.05),而对照组的这些变量保持不变。低密度脂蛋白、总胆固醇以及Kt/V、蛋白质分解代谢率、甲状旁腺激素、白蛋白和体重均未改变。未发现脂蛋白脂肪酶活性有变化。在第二项研究中,以交叉方式比较了单次使用高通量聚砜膜和低通量纤维素基膜进行血液透析对脂质参数和脂解活性的影响。两种膜治疗均导致血浆甘油三酯、VLDL甘油三酯和VLDL胆固醇显著降低。血液透析期间脂蛋白脂肪酶活性增加。两种治疗期间脂质参数和脂解活性的变化相同。